PATONE: Did Patone et al. report elevated risk of myocarditis, pericarditis, and cardiac arrhythmias with the COVID mRNA technology based gene injection vaccine? Yes!
by Paul Alexander
‘found increased risks myocarditis associated with first dose of ChAdOx1 and Pfizer BNT162b2 vaccines and the first and second doses of the Moderna mRNA-1273 vaccine over the 1–28 days postvaccine'
‘a self-controlled case series study of people aged 16 or older vaccinated for COVID-19 in England between 1 December 2020 and 24 August 2021 to investigate hospital admission or death from myocarditis, pericarditis and cardiac arrhythmias in the 1–28 days following adenovirus (ChAdOx1, n = 20,615,911) or messenger RNA-based (Pfizer BNT162b2, n = 16,993,389; Moderna mRNA-1273, n = 1,006,191) vaccines or a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive test (n = 3,028,867).’
Researchers ‘found increased risks of myocarditis associated with the first dose of ChAdOx1 and Pfizer BNT162b2 vaccines and the first and second doses of the Moderna mRNA-1273 vaccine over the 1–28 days postvaccination period, and after a SARS-CoV-2 positive test.’
‘Subgroup analyses by age showed the increased risk of myocarditis associated with the two mRNA vaccines was present only in those younger than 40.’